| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


The Clayton Foundation Laboratories for Peptide Biology, The Salk Institute La Jolla, California 92037
the Department of Physiology, Queens University (A.V.F.) Kingston, Ontario, Canada K7L 3N6
Address requests for reprints to: Dr. Paul M. Plotsky, Laboratory for Peptide Biology, The Salk Institute, P.O. Box 85800, San Diego, California 92138.
Abstract
It has been suggested that ACTH secretion in response to selected stimuli may be modulated by angiotensin II (All) via direct action at the level of the corticotrope or through central actions to facilitate CRF secretion into the hypophysialportal circulation. These hypotheses were evaluated in the present series of experiments. Our failure to observe a significant portal to peripheral plasma immunoreactive (ir) All gradient suggested that All does not act as a physiologically significant ACTH secretagogue at the level of the corticotrope. Central administration of synthetic All evoked a modest dose-related stimulation of hypothalamic irCRF secretion into the portal circulation, which was reversed by the All receptor antagonist saralasin. Activation of a known All-positive neuronal pathway projecting from the subfornical organ (SFO) to the hypothalamic paraventricular nuclei resulted in an elevation of hypophysialportal plasma irCRF levels and increased circulating ACTH. Pretreatment with saralasin prevented SFO stimulation-induced irCRF secretion. These observations suggest that central Allcontaining pathways may participate in mediation of ACTH secretion in response to hypovolemia or hyperosmolality by facilitating irCRF secretion. Involvement of the SFO, a circumventricular organ, in this circuit is intriguing as it provides a means of monitoring peripheral irAII concentration and then converting this humoral signal into a neural signal distributed to regions regulating drinking behavior, neurohypophysial AVP secretion, and activation of the hypothalamic-pituitary-adrenal axis (Endocrinology 122: 538–545, 1988)
Footnotes
* This work was supported by NIH Grant AM-33093 (to P.M.P.), the Medical Research Council of Canada (to A.V.F.). Research was conducted in part by the Clayton Foundation for Research, California Division.
Clayton Foundation Investigator.
Present address: Division of Endocrinology, Rhode Island Hospital, Providence, Rhode Island 02093.
Received June 9, 1987.
This article has been cited by other articles:
![]() |
E. G. Krause, S. J. Melhorn, J. F. Davis, K. A. Scott, L. Y. Ma, A. D. de Kloet, S. C. Benoit, S. C. Woods, and R. R. Sakai Angiotensin Type 1 Receptors in the Subfornical Organ Mediate the Drinking and Hypothalamic-Pituitary-Adrenal Response to Systemic Isoproterenol Endocrinology, December 1, 2008; 149(12): 6416 - 6424. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Latchford and A. V. Ferguson Angiotensin depolarizes parvocellular neurons in paraventricular nucleus through modulation of putative nonselective cationic and potassium conductances Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2005; 289(1): R52 - R58. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Porter and K. R. Potratz Effect of intracerebroventricular angiotensin II on body weight and food intake in adult rats Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R422 - R428. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Ziegler and J. P. Herman Neurocircuitry of Stress Integration: Anatomical Pathways Regulating the Hypothalamo-Pituitary-Adrenocortical Axis of the Rat Integr. Comp. Biol., July 1, 2002; 42(3): 541 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Ferguson, D. L.S. Washburn, and K. J. Latchford Hormonal and Neurotransmitter Roles for Angiotensin in the Regulation of Central Autonomic Function Experimental Biology and Medicine, February 1, 2001; 226(2): 85 - 96. [Abstract] [Full Text] |
||||
![]() |
M. P. Lilly and D. S. Gann The Hypothalamic-Pituitary-Adrenal--Immune Axis: A Critical Assessment Arch Surg, December 1, 1992; 127(12): 1463 - 1474. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |